Dedicated to reducing disability and death caused by stroke and other neurovascular diseases
Anaconda Biomed S.L. is a Barcelona-based medical device start-up developing next-generation endovascular access and protection.
ANACONDA'S Platform represents the introduction of a new category of neurovascular medical devices designed to address current limitations and provide efficient treatments by reducing the mortality and disability risks associated with common pathologies and corresponding techniques.
The platform is purposely designed for neurointerventions, including mechanical thrombectomy in cases of large vessel occlusion acute ischemic stroke. The ANA funnel is a self-expanding, atraumatic, funnel-based catheter designed to provide:
- High-efficiency aspiration
- Controlled flow arrest
- Minimized embolic risk
- A larger receptacle for clot collection
It is a sterile, single-use catheter comprised of a radiopaque nitinol braid shaped in a unique self-expanding funnel covered by a continuous silicone coating that enables local flow restriction when deployed.
Intended Use
The ANA5 system is intended to be inserted and navigated to the neurovascular anatomy inside an outer catheter and be used as a conduit for the insertion and guidance of intravascular catheters and retrieval devices into a selected blood vessel. The funnel is deployed by retracting the conduit catheter and is intended, when deployed, to provide temporary vascular flow restriction.
The device is indicated for the introduction of interventional devices into the neuro vasculature, during interventions for restoring blood flow in patients experiencing an acute ischemic stroke due to large vessel occlusion.
The device is indicated for the introduction of interventional devices into the neuro vasculature, during interventions for restoring blood flow in patients experiencing an acute ischemic stroke due to large vessel occlusion.